Table 2.
Type of the polymerization initiation |
Component | Acronym | Mass fraction % |
---|---|---|---|
Light-cure (LC) | |||
LC1 | Camphorquinone Ethyl-4-N,N-dimethylamino benzoate |
CQ 4EDMAB |
0.2 0.8 |
---------------------------------------------- | |||
LC2 | -Bis(2,6-dimethoxybenzoyl)-2,4,4- trimethylpentyl phosphine oxide & 1-hydroxycyclohexyl phenyl ketone |
1850 IRGACURE |
1.0 |
---------------------------------------------- | |||
LC3 | - Camphorquinone Ethyl-4-N,N-dimethylamino benzoate Diphenyl(2,4,6-trimethylbenzoyl) phosphine oxide & 2-hydroxy-2- methyl-1-phenyl-1- propanone 2-Benzyl-2-(dimethylamino)-1-(4- (4-morpholinyl)phenyl)-1-butanone |
CQ 4EDMAB 4265 DAROCUR 369 IRGACURE |
0.4 0.4 0.8 1.5 |
| |||
Chemical-cure (CC) | |||
CC1 | Benzoyl peroxide 2,2′-Dihydroxyethyl-p-toluidine |
BPO DHEPT |
2.0 1.0 |
---------------------------------------------- | |||
CC2 | - L(+) ascorbic acid t-Butyl perbenzoate |
AA TBPB |
0.5 1.0 |
| |||
Dual-cure (DC) | |||
DC1 | Bis(2,6-dimethoxybenzoyl)-2,4,4- trimethylpentyl phosphine oxide & 1-hydroxycyclohexyl phenyl ketone Benzoyl peroxide 2,2′-Dihydroxyethyl-p-toluidine |
1850 IRGACURE BPO DHEPT |
1.0 2.0 1.0 |
---------------------------------------------- | |||
DC2 | - Bis(2,6-dimethoxybenzoyl)-2,4,4- trimethylpentyl phosphine oxide & 1-hydroxycyclohexyl phenyl ketone L(+) ascorbic acid t-Butyl perbenzoate |
1850 IRGACURE AA TBPB |
1.0 0.5 1.0 |